A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma

Cancer

Volumn 91, Issue 10, 2001, Pages 1854-1861

  Pujol, Pascal ^a   Daures, Jean Pierre ^a   Brouillet, Jean Paul ^b   Chang, Shine ^c   Rouanet, Phillipe ^d   Bringer, Jacques ^a   Grenier, Jean ^a   Maudelonde, Thierry ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Anticancer Center   (France)

Author keywords

Breast carcinoma; Estrogen; Gonadotropin; Menstrual cycle; Progesterone; Prognosis

Indexed keywords

CATHEPSIN D; ESTROGEN; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; ESTROGEN BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PREDICTION; PREMENOPAUSE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGNOSIS; TUMOR VOLUME;

BREAST NEOPLASMS; CATHEPSIN D; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MENSTRUAL CYCLE; MULTIVARIATE ANALYSIS; PREMENOPAUSE; PROGESTERONE; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TIME FACTORS;

EID: 0035873135     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010515)91:10<1854::AID-CNCR1206>3.0.CO;2-Y     Document Type: Article

References (34)

1. Estrous influence on surgical cure of mouse breast cancer
2. Menstrual influence on surgical cure of breast cancer
3. A prospective study of endogenous estrogens and breast cancer in postmenopausal women
4. Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer
5. Serum progesterone and prognosis in operable breast cancer
6. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer
7. Timing of breast cancer excision during the menstrual cycle influences the duration of disease-free survival
8. Effect of menstrual phase on surgical treatment of breast cancer
9. Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient - Fact or fallacy
10. Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: Results of the International Breast Cancer Study Group (IBCSG) Trial VI
11. Breast cancer survival and the timing of tumor removal during the menstrual cycle
12. Breast cancer and timing of surgery during menstrual cycle: A 5-year analysis of 248 premenopausal women
13. Survival of premenopausal breast carcinoma patients in relation to menstrual cycle: Timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor
14. Effect of menstrual phase on surgical treatment of breast cancer
15. Unopposed oestrogen and survival of breast cancer
16. Menstrual surgical timing
17. Timing of breast cancer surgery within the menstrual cycle: Influence on lymph-node involvement, receptor status, postoperative metastatic spread and local recurrence
18. Timing of breast cancer surgery
19. Menstrual status and breast cancer surgery
20. Timing of surgery in relation to menstrual cycle does not predict the prognosis in primary breast cancer
21. Timing of surgery during the menstrual cycle does not influence survival in breast cancer
22. Breast cancer and timing of surgery during menstrual cycle. A 5-year analysis of 385 pre-menopausal women
23. Menstrual phase and breast cancer surgery: Influence on clinical outcome or pitfall of statistical analysis?
24. Optimal mastectomy timing
25. Breast cancer prognostic factors: Evaluation guidelines
26. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause
27. Timing of surgery during the menstrual cycle and menopause for breast cancer affects ps2 level but not cathepsin D
28. Timing of surgery during the menstrual cycle for breast cancer: Possible role of growth factors
29. Vascular endothelial growth factor in premenopausal women-indicator of the best time for breast cancer surgery?
30. Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases
31. Luteinizing hormone-releasing hormone analogues - The rationale for adjuvant use in premenopausal women with early breast cancer
32. Luteinizing hormone-releasing hormone analogs: Their impact on the control of tumorigenesis
33. Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer
34. The modulation of gonadotrophic hormone action on the ovary by paracrine and autocrine factors